한글목차

개요

혈액 분석기·시약 시장은 2023-2028년 39억 1,160만 달러, 예측 기간 중 CAGR은 6.95%로 성장할 것으로 예측되고 있습니다.

혈액 분석기·시약 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 제공합니다.

현재의 시장 시나리오, 최신 동향과 촉진요인, 시장 환경 전체에 관한 최신 분석을 제공하고 있습니다. 시장은 중소규모 검사실에서 혈액 분석기 솔루션의 채택 증가, POC(Point of Care) 검사의 채택 확대, 맞춤형 의약품의 수요 증가가 촉진하고 있습니다.

본 조사에서는 향후 수년간 혈액 분석기·시약 시장 성장을 촉진하는 주요 요인의 하나로 의료 분야에서 자동화 시스템 이용의 증가를 들고 있습니다. 또한 혈액 질환의 유병률 증가 및 의료 지출의 증가는 시장의 큰 수요로 연결됩니다.

목차

제1장 주요 요약

• 시장 개요

제2장 시장 구도

• 시장 에코시스템

제3장 시장 규모 파악

• 시장의 정의
• 시장 부문 분석
• 시장 규모 2023년
• 시장의 전망 2023-2028년

제4장 시장 규모 실적

• 세계의 혈액 분석기·시약 시장 2018-2022년
• 제품별 부문 분석 2018-2022년
• 최종사용자별 부문 분석 2018-2022년
• 지역별 부문 분석 2018-2022년
• 국가별 부문 분석 2018-2022년

제5장 Five forces 분석

• Five Forces 요약
• 구매자의 교섭력
• 공급 기업의 교섭력
• 신규 진출업체의 위협
• 대체품의 위협
• 경쟁의 위협
• 시장 현황

제6장 시장 세분화 : 제품별

• 시장 부문
• 비교 : 제품별
• 시약 및 소모품 : 시장 규모와 예측 2023-2028년
• 기기 : 시장 규모와 예측 2023-2028년
• 시장 기회 : 제품별

제7장 시장 세분화 : 최종사용자별

• 시장 부문
• 비교 : 최종사용자별
• 병원 : 시장 규모와 예측 2023-2028년
• 임상 검사실 : 시장 규모와 예측 2023-2028년
• 연구기관 : 시장 규모와 예측 2023-2028년
• 기타 : 시장 규모와 예측 2023-2028년
• 시장 기회 : 최종사용자별

제8장 고객 상황

• 고객 상황 개요

제9장 지역별 상황

• 지역별 세분화
• 지역별 비교
• 북미 : 시장 규모와 예측 2023-2028년
• 아시아 : 시장 규모와 예측 2023-2028년
• 유럽 : 시장 규모와 예측 2023-2028년
• 세계의 기타 중동 및 아프리카 : 시장 규모와 예측 2023-2028년
• 미국 : 시장 규모와 예측 2023-2028년
• 중국 : 시장 규모와 예측 2023-2028년
• 캐나다 : 시장 규모와 예측 2023-2028년
• 독일 : 시장 규모와 예측 2023-2028년
• 일본 : 시장 규모와 예측 2023-2028년
• 시장 기회 : 지역 상황별

제10장 촉진요인, 과제 및 동향

• 시장 촉진요인
• 시장이 해결해야 할 과제
• 촉진요인과 과제의 영향
• 시장 동향

제11장 벤더 구도

• 개요
• 벤더 구도
• 혼란의 상황
• 업계의 리스크

제12장 벤더 분석

• 대상 벤더
• 벤더의 시장 포지셔닝
• Abbott Laboratories
• Bio Rad Laboratories Inc.
• BioSystems SA
• Boule Diagnostics AB
• Danaher Corp.
• EKF Diagnostics Holdings Plc
• F. Hoffmann La Roche Ltd.
• Heska Corp.
• HORIBA Ltd.
• Mindray Bio medical Electronics Co. Ltd.
• Nihon Kohden Corp.
• Siemens AG
• STRATEC SE
• Sysmex Corp.
• Zoetis Inc.

제13장 부록

영문목차

Abstract

The hematology analyzers and reagents market is forecasted to grow by USD 3911.6 mn during 2023-2028, accelerating at a CAGR of 6.95% during the forecast period. The report on the hematology analyzers and reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase adoption of hematology analyzer solutions for smaller and mid-sized laboratories, growing adoption of point-of-care testing, and increasing demand for personalized medicines.

Technavio's hematology analyzers and reagents market is segmented as below:

By Product

• Reagents and consumables
• Instruments

By End-user

• Hospitals
• Clinical laboratories
• Research institute
• Others

By Geographical Landscape

• North America
• Asia
• Europe
• Rest of World (ROW)

This study identifies the increasing use of automated systems in healthcare sector as one of the prime reasons driving the hematology analyzers and reagents market growth during the next few years. Also, increasing prevalence of blood disorders and increased healthcare expenditure will lead to sizable demand in the market.

The report on the hematology analyzers and reagents market covers the following areas:

• Hematology analyzers and reagents market sizing
• Hematology analyzers and reagents market forecast
• Hematology analyzers and reagents market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hematology analyzers and reagents market vendors that include Abbott Laboratories, Bio Rad Laboratories Inc., BioSystems SA, Boule Diagnostics AB, Danaher Corp., EKF Diagnostics Holdings Plc, Erba Diagnostics FZ LLC, F. Hoffmann La Roche Ltd., Heska Corp., HORIBA Ltd., Mindray Bio medical Electronics Co. Ltd., NeoMedica, Nihon Kohden Corp., Siemens AG, STRATEC SE, Sysmex Corp., Thermo Fisher Scientific Inc., Toyobo Co. Ltd., URIT Medical Electronic Co. Ltd., and Zoetis Inc.. Also, the hematology analyzers and reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
• Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
• Exhibit 07: Executive Summary - Chart on Incremental Growth
• Exhibit 08: Executive Summary - Data Table on Incremental Growth
• Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 13: Market segments
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028
• Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

• 4.1 Global hematology analyzers and reagents market 2018 - 2022
• Exhibit 18: Historic Market Size - Data Table on global hematology analyzers and reagents market 2018 - 2022 ($ million)
• 4.2 Product Segment Analysis 2018 - 2022
• Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ million)
• 4.3 End-user Segment Analysis 2018 - 2022
• Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ million)
• 4.4 Geography Segment Analysis 2018 - 2022
• Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 4.5 Country Segment Analysis 2018 - 2022
• Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

• 5.1 Five forces summary
• Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
• 5.2 Bargaining power of buyers
• Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• 5.3 Bargaining power of suppliers
• Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 5.4 Threat of new entrants
• Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
• 5.5 Threat of substitutes
• Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
• 5.6 Threat of rivalry
• Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
• 5.7 Market condition
• Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product

• 6.1 Market segments
• Exhibit 30: Chart on Product - Market share 2023-2028 (%)
• Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
• 6.2 Comparison by Product
• Exhibit 32: Chart on Comparison by Product
• Exhibit 33: Data Table on Comparison by Product
• 6.3 Reagents and consumables - Market size and forecast 2023-2028
• Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2023-2028 ($ million)
• Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2023-2028 ($ million)
• Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2023-2028 (%)
• Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2023-2028 (%)
• 6.4 Instruments - Market size and forecast 2023-2028
• Exhibit 38: Chart on Instruments - Market size and forecast 2023-2028 ($ million)
• Exhibit 39: Data Table on Instruments - Market size and forecast 2023-2028 ($ million)
• Exhibit 40: Chart on Instruments - Year-over-year growth 2023-2028 (%)
• Exhibit 41: Data Table on Instruments - Year-over-year growth 2023-2028 (%)
• 6.5 Market opportunity by Product
• Exhibit 42: Market opportunity by Product ($ million)
• Exhibit 43: Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by End-user

• 7.1 Market segments
• Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
• Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)
• 7.2 Comparison by End-user
• Exhibit 46: Chart on Comparison by End-user
• Exhibit 47: Data Table on Comparison by End-user
• 7.3 Hospitals - Market size and forecast 2023-2028
• Exhibit 48: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 49: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
• Exhibit 50: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
• Exhibit 51: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
• 7.4 Clinical laboratories - Market size and forecast 2023-2028
• Exhibit 52: Chart on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
• Exhibit 53: Data Table on Clinical laboratories - Market size and forecast 2023-2028 ($ million)
• Exhibit 54: Chart on Clinical laboratories - Year-over-year growth 2023-2028 (%)
• Exhibit 55: Data Table on Clinical laboratories - Year-over-year growth 2023-2028 (%)
• 7.5 Research institute - Market size and forecast 2023-2028
• Exhibit 56: Chart on Research institute - Market size and forecast 2023-2028 ($ million)
• Exhibit 57: Data Table on Research institute - Market size and forecast 2023-2028 ($ million)
• Exhibit 58: Chart on Research institute - Year-over-year growth 2023-2028 (%)
• Exhibit 59: Data Table on Research institute - Year-over-year growth 2023-2028 (%)
• 7.6 Others - Market size and forecast 2023-2028
• Exhibit 60: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 61: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibit 62: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibit 63: Data Table on Others - Year-over-year growth 2023-2028 (%)
• 7.7 Market opportunity by End-user
• Exhibit 64: Market opportunity by End-user ($ million)
• Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
• Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
• Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
• Exhibit 69: Chart on Geographic comparison
• Exhibit 70: Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Asia - Market size and forecast 2023-2028
• Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.5 Europe - Market size and forecast 2023-2028
• Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
• Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 China - Market size and forecast 2023-2028
• Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.9 Canada - Market size and forecast 2023-2028
• Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.10 Germany - Market size and forecast 2023-2028
• Exhibit 99: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 100: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibit 101: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibit 102: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• 9.11 Japan - Market size and forecast 2023-2028
• Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• 9.12 Market opportunity By Geographical Landscape
• Exhibit 107: Market opportunity By Geographical Landscape ($ million)
• Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• Exhibit 109: Impact of drivers and challenges in 2023 and 2028
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
• 11.3 Landscape disruption
• Exhibit 111: Overview on factors of disruption
• 11.4 Industry risks
• Exhibit 112: Impact of key risks on business

12 Vendor Analysis

• 12.1 Vendors covered
• Exhibit 113: Vendors covered
• 12.2 Market positioning of vendors
• Exhibit 114: Matrix on vendor position and classification
• 12.3 Abbott Laboratories
• Exhibit 115: Abbott Laboratories - Overview
• Exhibit 116: Abbott Laboratories - Business segments
• Exhibit 117: Abbott Laboratories - Key news
• Exhibit 118: Abbott Laboratories - Key offerings
• Exhibit 119: Abbott Laboratories - Segment focus
• 12.4 Bio Rad Laboratories Inc.
• Exhibit 120: Bio Rad Laboratories Inc. - Overview
• Exhibit 121: Bio Rad Laboratories Inc. - Business segments
• Exhibit 122: Bio Rad Laboratories Inc. - Key news
• Exhibit 123: Bio Rad Laboratories Inc. - Key offerings
• Exhibit 124: Bio Rad Laboratories Inc. - Segment focus
• 12.5 BioSystems SA
• Exhibit 125: BioSystems SA - Overview
• Exhibit 126: BioSystems SA - Product / Service
• Exhibit 127: BioSystems SA - Key offerings
• 12.6 Boule Diagnostics AB
• Exhibit 128: Boule Diagnostics AB - Overview
• Exhibit 129: Boule Diagnostics AB - Product / Service
• Exhibit 130: Boule Diagnostics AB - Key offerings
• 12.7 Danaher Corp.
• Exhibit 131: Danaher Corp. - Overview
• Exhibit 132: Danaher Corp. - Business segments
• Exhibit 133: Danaher Corp. - Key news
• Exhibit 134: Danaher Corp. - Key offerings
• Exhibit 135: Danaher Corp. - Segment focus
• 12.8 EKF Diagnostics Holdings Plc
• Exhibit 136: EKF Diagnostics Holdings Plc - Overview
• Exhibit 137: EKF Diagnostics Holdings Plc - Business segments
• Exhibit 138: EKF Diagnostics Holdings Plc - Key offerings
• Exhibit 139: EKF Diagnostics Holdings Plc - Segment focus
• 12.9 F. Hoffmann La Roche Ltd.
• Exhibit 140: F. Hoffmann La Roche Ltd. - Overview
• Exhibit 141: F. Hoffmann La Roche Ltd. - Business segments
• Exhibit 142: F. Hoffmann La Roche Ltd. - Key news
• Exhibit 143: F. Hoffmann La Roche Ltd. - Key offerings
• Exhibit 144: F. Hoffmann La Roche Ltd. - Segment focus
• 12.10 Heska Corp.
• Exhibit 145: Heska Corp. - Overview
• Exhibit 146: Heska Corp. - Business segments
• Exhibit 147: Heska Corp. - Key news
• Exhibit 148: Heska Corp. - Key offerings
• Exhibit 149: Heska Corp. - Segment focus
• 12.11 HORIBA Ltd.
• Exhibit 150: HORIBA Ltd. - Overview
• Exhibit 151: HORIBA Ltd. - Business segments
• Exhibit 152: HORIBA Ltd. - Key offerings
• Exhibit 153: HORIBA Ltd. - Segment focus
• 12.12 Mindray Bio medical Electronics Co. Ltd.
• Exhibit 154: Mindray Bio medical Electronics Co. Ltd. - Overview
• Exhibit 155: Mindray Bio medical Electronics Co. Ltd. - Product / Service
• Exhibit 156: Mindray Bio medical Electronics Co. Ltd. - Key offerings
• 12.13 Nihon Kohden Corp.
• Exhibit 157: Nihon Kohden Corp. - Overview
• Exhibit 158: Nihon Kohden Corp. - Product / Service
• Exhibit 159: Nihon Kohden Corp. - Key news
• Exhibit 160: Nihon Kohden Corp. - Key offerings
• 12.14 Siemens AG
• Exhibit 161: Siemens AG - Overview
• Exhibit 162: Siemens AG - Business segments
• Exhibit 163: Siemens AG - Key news
• Exhibit 164: Siemens AG - Key offerings
• Exhibit 165: Siemens AG - Segment focus
• 12.15 STRATEC SE
• Exhibit 166: STRATEC SE - Overview
• Exhibit 167: STRATEC SE - Business segments
• Exhibit 168: STRATEC SE - Key offerings
• Exhibit 169: STRATEC SE - Segment focus
• 12.16 Sysmex Corp.
• Exhibit 170: Sysmex Corp. - Overview
• Exhibit 171: Sysmex Corp. - Business segments
• Exhibit 172: Sysmex Corp. - Key offerings
• Exhibit 173: Sysmex Corp. - Segment focus
• 12.17 Zoetis Inc.
• Exhibit 174: Zoetis Inc. - Overview
• Exhibit 175: Zoetis Inc. - Business segments
• Exhibit 176: Zoetis Inc. - Key news
• Exhibit 177: Zoetis Inc. - Key offerings
• Exhibit 178: Zoetis Inc. - Segment focus

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• Exhibit 179: Inclusions checklist
• Exhibit 180: Exclusions checklist
• 13.3 Currency conversion rates for US$
• Exhibit 181: Currency conversion rates for US$
• 13.4 Research methodology
• Exhibit 182: Research methodology
• Exhibit 183: Validation techniques employed for market sizing
• Exhibit 184: Information sources
• 13.5 List of abbreviations
• Exhibit 185: List of abbreviations